retatrutide gip glp-1 glucagon receptor agonist Science Behind GLP 1 and Agonists for Obesity Research | News & Announcements Retatrutide | GLP-1R/GIPR/GCGR ligand |

Expert consensus suggests that patients taking GLP-1 receptor agonists or dual GIP/GLP-1 receptor agonists may benefit from 1.01.5 grams of protein per kilogram of ideal or adjusted body weight daily to support lean muscle mass preservation

Semaglutide, the drug in Ozempic and Wegovy, is a GLP-1R agonist only

The concept of peptide dosing principles applies across all injectable peptides, and understanding them helps you appreciate why the starting dose approach exists in the first place

Results vary, but some people report milder side effects with tirzepatide

Yes, treatment options are available and can be tailored to your specific situation

Patients with energy or metabolism goals often see best results with weekly shots